4-butyrolactone has been researched along with Astrocytoma, Grade IV in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, L; Hung, SH; Mody, A; Svoronos, SA; Tseng, Y; Wang, C; Yin, J | 1 |
| Dünisch, P; Ewald, C; Freitag, D; Grube, S; Kalff, R; Klausnitzer, M; Sakr, Y; Walter, J | 1 |
| Chiou, TW; Harn, HJ; Ho, LI; Lin, SZ; Su, HL; Tao, M; Tsai, SF | 1 |
3 other study(ies) available for 4-butyrolactone and Astrocytoma, Grade IV
| Article | Year |
|---|---|
The Effect of Z-Ligustilide on the Mobility of Human Glioblastoma T98G Cells.
Topics: 4-Butyrolactone; cdc42 GTP-Binding Protein; Cell Line, Tumor; Cell Movement; Cytoskeleton; Glioblastoma; Humans; Neoplasm Proteins; rac1 GTP-Binding Protein; rhoA GTP-Binding Protein | 2013 |
Overexpression of fatty acid synthase in human gliomas correlates with the WHO tumor grade and inhibition with Orlistat reduces cell viability and triggers apoptosis.
Topics: 4-Butyrolactone; Apoptosis; Autophagy; Brain; Brain Neoplasms; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Cerulenin; Dose-Response Relationship, Drug; Fatty Acid Synthase, Type I; Fatty Acid Synthesis Inhibitors; Glioblastoma; Glioma; Humans; Lactones; Neoplasm Grading; Orlistat; Tissue Culture Techniques | 2014 |
Isochaihulactone-induced DDIT3 causes ER stress-PERK independent apoptosis in glioblastoma multiforme cells.
Topics: 4-Butyrolactone; Animals; Antineoplastic Agents, Phytogenic; Benzodioxoles; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Survival; eIF-2 Kinase; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Gene Expression Regulation, Neoplastic; Glioblastoma; Growth Differentiation Factor 15; Humans; Mice; Transcription Factor CHOP; Treatment Outcome; Xenograft Model Antitumor Assays | 2017 |